FeesSafety
Pluang+

Microvast schedules Q3 2026 earnings release and call for November 9

Company Fundamentals
27 Oct 2026, 00:00 WIB
GlobeNewsWire
View Source
Neutral
Microvast schedules Q3 2026 earnings release and call for November 9

Microvast Holdings, a leader in advanced battery technology, announced it will release its third quarter 2026 financial results on November 9 after market close. The company will hold a webcast and conference call to discuss the results and outlook at 4 p.m. Central Time. This event provides investors insight into Microvast's financial health and future plans amid its mission to lead in battery innovation.

Microvast's upcoming Q3 earnings call is noted here with Pluang's Technology sector data as context. As of Oct 27, 2026 02:51 WIB, 81 of 150 US tech stocks rose, 65 fell. Notable movers include AXTI at USD 56.12 (+7.76%), DOCN at USD 100.01 (+7.28%), and NOK at USD 8.64 (+6.20%). Typical hold times range from 18 to 66 days, with varied buy-sell order activity.

More News

Presidio named Global Innovation Partner of the Year at Cisco Partner Summit 2026

Presidio named Global Innovation Partner of the Year at Cisco Partner Summit 2026

At the Cisco Partner Summit 2026, Presidio was honored as the Global Innovation Partner of the Year, recognizing its outstanding innovation and success in delivering impactful customer solutions. This award highlights Presidio's commitment to partner...

Market News
Bullish
57 minutes ago
Presidio named Global Services and Software Excellence Partner of the Year at Cisco Partner Summit 2026

Presidio named Global Services and Software Excellence Partner of the Year at Cisco Partner Summit 2026

Presidio was awarded the Global Services and Software Excellence Partner of the Year at the Cisco Partner Summit 2026. This award recognizes Presidio's outstanding innovation and success in delivering solutions that help customers achieve meaningful ...

Market News
Bullish
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
2 hours ago
Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
2 hours ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App